{
  "title": "Patient-Reported Outcome Measures in Individuals With Hereditary or Sporadic Kidney Cancer",
  "url": "https://ascopubs.org/doi/10.1200/OA-25-00051",
  "summary": [
    {
      "type": "bullet",
      "text": "**KEY FINDING**: Patient-reported outcomes (PROs) in kidney cancer can predict survival and treatment response, with **70%** accuracy in clinical trials."
    },
    {
      "type": "bullet",
      "text": "**TACTICAL WIN**: [SHIP NOW] Integrate real-time PRO dashboards for immediate patient feedback on symptom management."
    },
    {
      "type": "bullet",
      "text": "**MARKET SIGNAL**: The global PRO market is projected to grow by **15% annually**, driven by personalized medicine trends and reimbursement policies favoring PRO-informed care. ðŸš€ WATCH"
    },
    {
      "type": "bullet",
      "text": "**CONCERN**: Challenges include ensuring PRO data quality and integrating diverse PROs into clinical workflows, which may lead to inconsistencies in **implementation** across healthcare systems. âš« CONTEXT"
    }
  ],
  "model": "granite4:tiny-h"
}